Results 11 to 20 of about 207,197 (306)

Influenza and Influenza Vaccine: A Review [PDF]

open access: yesJournal of Midwifery & Women's Health, 2021
AbstractInfluenza is a highly contagious, deadly virus, killing nearly half a million people yearly worldwide. The classic symptoms of influenza are fever, fatigue, cough, and body aches. In the outpatient setting, diagnosis can be made by clinical presentation with optional confirmatory diagnostic testing.
Cynthia Nypaver   +2 more
openaire   +2 more sources

Influenza vaccination

open access: yesNursing Older People, 1999
Nurses have an important part to play in dispelling myths about influenza vaccination and in actively encouraging older people to attend for vaccination. Irene Schofield discusses the issues.
A, Uma, P, Thirumalaikolundusubramanian
openaire   +5 more sources

Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study

open access: yesFrontiers in Immunology, 2023
IntroductionThe haemagglutination inhibition assay (HAI) and the virus microneutralisation assay (MN) are long-established methods for quantifying antibodies against influenza viruses. Despite their widespread use, both assays require standardisation to
Joanna Waldock   +22 more
doaj   +1 more source

Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden

open access: yesVaccine: X, 2023
Introduction: Current influenza vaccines have limited effectiveness. COVID-19 vaccines using mRNA technology have demonstrated very high efficacy, suggesting that mRNA vaccines could be more effective for influenza. Several such influenza vaccines are in
Mary G. Krauland   +6 more
doaj   +1 more source

Influenza Vaccines

open access: yesNature Reviews Drug Discovery, 2006
Mark J, Belsey   +3 more
europepmc   +3 more sources

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines

open access: yesVaccines, 2022
Influenza is a vaccine preventable disease and vaccination remains the most effective method of controlling the morbidity and mortality of seasonal influenza, especially with respect to risk groups.
Claudia Maria Trombetta   +4 more
doaj   +1 more source

Engineered Nanoparticulate Vaccines to Combat Recurring and Pandemic Influenza Threats

open access: yesAdvanced NanoBiomed Research, 2022
Recurring seasonal flu epidemics and occasional pandemics are among the most severe threats to public health. Current seasonal influenza vaccines provide limited protection against drifted circulating strains and no protection against influenza pandemics.
Chunhong Dong, Bao-Zhong Wang
doaj   +1 more source

Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China

open access: yesVaccines, 2021
Background: Following the COVID-19 pandemic, global interest in influenza vaccines and pneumonia vaccines has increased significantly. We aimed to examine public interest in and actual market circulation of influenza and pneumonia vaccines before and ...
Liubing Gong   +8 more
doaj   +1 more source

Chemical-free inactivated whole influenza virus vaccine prepared by ultrashort pulsed laser treatment [PDF]

open access: yes, 2014
There is an urgent need for rapid methods to develop vaccines in response to emerging viral pathogens. Whole inactivated virus (WIV) vaccines represent an ideal strategy for this purpose; however, a universal method for producing safe and immunogenic ...
Achilefu, Samuel   +10 more
core   +2 more sources

Animal Models Utilized for the Development of Influenza Virus Vaccines

open access: yesVaccines, 2021
Animal models have been an important tool for the development of influenza virus vaccines since the 1940s. Over the past 80 years, influenza virus vaccines have evolved into more complex formulations, including trivalent and quadrivalent inactivated ...
Ericka Kirkpatrick Roubidoux   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy